TickerFacts.

NRC Health (NRC): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$15.74M
Year ended 2025-12-31
$21.64M
Trailing 12 months to 2026-06-30
-15.9%
3-year compound annual growth
-15.5%
5-year compound annual growth
-1.8%
10-year compound annual growth
$40.83M2009-12-31: $10.76M2010-12-31: $13.06M2011-12-31: $15.67M2012-12-31: $16.78M2013-12-31: $17.13M2014-12-31: $23.70M2015-12-31: $18.95M2016-12-31: $22.87M2017-12-31: $23.52M2018-12-31: $33.88M2019-12-31: $36.26M2020-12-31: $36.65M2021-12-31: $40.83M2022-12-31: $26.43M2023-12-31: $22.33M2024-12-31: $19.18M2025-12-31: $15.74M$15.74M
2009-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$15.74M-17.9%2026-03-05, From 2025-01-01
2024-12-31$19.18M-14.1%2026-03-05, From 2024-01-01
2023-12-31$22.33M-15.5%2026-03-05, From 2023-01-01
2022-12-31$26.43M-35.3%2025-03-17, From 2022-01-01
2021-12-31$40.83M+11.4%2024-02-27, From 2021-01-01
2020-12-31$36.65M+1.1%2023-03-03, From 2020-01-01
2019-12-31$36.26M+7.0%2022-03-04, From 2019-01-01
2018-12-31$33.88M+44.0%2021-03-05, From 2018-01-01
2017-12-31$23.52M+2.9%2020-03-06, From 2017-01-01
2016-12-31$22.87M+20.7%2019-03-08, From 2016-01-01
2015-12-31$18.95M-20.1%2018-03-14, From 2015-01-01
2014-12-31$23.70M+38.4%2017-03-03, From 2014-01-01
2013-12-31$17.13M+2.0%2016-03-04, From 2013-01-01
2012-12-31$16.78M+7.1%2015-03-04, From 2012-01-01
2011-12-31$15.67M+19.9%2014-03-04, From 2011-01-01
2010-12-31$13.06M+21.4%2013-03-01, From 2010-01-01
2009-12-31$10.76Mn/a2012-03-01, From 2009-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
NRC Health (NRC)2025-12-31$15.74M-17.9%
MaxCyte, Inc. (MXCT)2025-12-31-$36.18Mn/m
OmniAb, Inc. (OABI)2025-12-31-$37.02Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$3.93Mn/a
Medpace Holdings, Inc. (MEDP)2025-12-31$681.87M+19.2%
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$9.39Mn/m
Charles River Laboratories International, Inc. (CRL)2025-12-27$518.49M+3.4%
Absci Corp (ABSI)2025-12-31-$94.03Mn/m
Icon PLC (ICLR)2025-12-31$861.99M-22.9%

Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗